One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.

@article{Lorette2000OneyearTO,
  title={One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.},
  author={G{\'e}rard Lorette and Alberto Giannetti and Rafaela Sarmento Pereira and Francisque Leynadier and Margarita Murrieta-Aguttes},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2000},
  volume={14 2},
  pages={83-90}
}
AIM To assess the long-term safety and efficacy of the H1-receptor antagonist mizolastine in the symptomatic treatment of chronic urticaria (CU). BACKGROUND Mizolastine is a novel second generation antihistamine with additional anti-inflammatory properties which has been shown to be effective in this condition as well as in allergic rhinitis. As the drug is used for chronic treatment, a detailed study of its efficacy and safety over a prolonged period was warranted. METHODS This open label… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…